Indeed, in animal studies, reduced skeletal muscle FNDC5 expression in ischemic cardiomyopathy was likely modulated by inflammatory cytokines and/or angiotensin-II via the down-regulated PGC-1α, which corresponded to low irisin production [47,48]. This evidence concerns the gene PPARGC1A and ischemic cardiomyopathy.